SUMF2 and type 2 diabetes mellitus: The results showed that the expression trends of PES1, CANX, SUMF2 and DCXR were consistent with the above predictions, especially SUMF2, which was not only reduced in T2DM and COPD patients, but also significantly reduced in patients with comorbidities compared with healthy controls.